No recent analyst price targets found for SBHMY.
Latest News for SBHMY
Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs
Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to market two respiratory drugs from British company GSK in mainland China.
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion
Hong Kong-listed Sino Biopharmaceutical said on Wednesday it has granted AstraZeneca the rights to develop a drug designed to treat chronic respiratory diseases outside China for total payments of up to $1.9 billion.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SBHMY.
Senate Trading
No Senate trades found for SBHMY.
U.S. House Trading
No House trades found for SBHMY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.